1. Home
  2. ZCMD
  3. ZCMD News

Latest Zhongchao Inc. (ZCMD) News on November 18, 2024

ZCMD

Business Wire

5 months ago

Net Asset Value(s)

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence
ZCMD

Business Wire

5 months ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon
ZCMD

Newsfile

5 months ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%
ZCMD

GlobeNewswire

5 months ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities
ZCMD

Business Wire

5 months ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
ZCMD

GlobeNewswire

5 months ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024
ZCMD

PR Newswire

5 months ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

Dstny honored with 'Employee Wellbeing Award'
ZCMD

PR Newswire

5 months ago

Dstny honored with 'Employee Wellbeing Award'

Zhongchao Full Year 2023 Earnings: US$4.35 loss per share (vs US$1.13 loss in FY 2022)
ZCMD

Simply Wall St.

7 months ago

Zhongchao Full Year 2023 Earnings: US$4.35 loss per share (vs US$1.13 loss in FY 2022)

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
ZCMD

PR Newswire

8 months ago

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

Zhongchao Inc. Announces 1-for-10 Share Consolidation
ZCMD

PR Newswire

9 months ago

Zhongchao Inc. Announces 1-for-10 Share Consolidation

Interactive Strength, Inc. is Expanding its Presence in the Fast-growing Golf Performance Market as a New Exhibitor at the 2024 PGA Show
ZCMD

NewMediaWire

10 months ago

Interactive Strength, Inc. is Expanding its Presence in the Fast-growing Golf Performance Market as a New Exhibitor at the 2024 PGA Show

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
ZCMD

Business Wire

10 months ago

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Exela Technologies and XBP Europe Announce the Launch of Reaktr.ai to Provide Cybersecurity, Data Modernization and Multi-Cloud Management Enabled by AI
ZCMD

GlobeNewswire

10 months ago

Exela Technologies and XBP Europe Announce the Launch of Reaktr.ai to Provide Cybersecurity, Data Modernization and Multi-Cloud Management Enabled by AI

True Velocity, FN America Approaching Launch of Conversion Kits for M240
ZCMD

GlobeNewswire

10 months ago

True Velocity, FN America Approaching Launch of Conversion Kits for M240

Sports Illustrated Announces Major Layoffs, Putting the Brand’s Future in Jeopardy
ZCMD

The Wall Street Journal

10 months ago

Sports Illustrated Announces Major Layoffs, Putting the Brand’s Future in Jeopardy

Fathom Realty Announces Promotion of DeJane Kerr to Senior Vice President of Operations
ZCMD

PR Newswire

10 months ago

Fathom Realty Announces Promotion of DeJane Kerr to Senior Vice President of Operations

NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of DA-1241 in Combination with Sitagliptin and Opens Enrollment for Part 2 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
ZCMD

PR Newswire

10 months ago

NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of DA-1241 in Combination with Sitagliptin and Opens Enrollment for Part 2 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH

Zacks Industry Outlook Highlights Donaldson, CECO Environmental and Fuel Tech
ZCMD

Zacks

10 months ago

Zacks Industry Outlook Highlights Donaldson, CECO Environmental and Fuel Tech

Silynxcom Ltd. Announces Pricing of Initial Public Offering
ZCMD

GlobeNewswire

10 months ago

Silynxcom Ltd. Announces Pricing of Initial Public Offering

ZCMD

Business Wire

10 months ago

AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
ZCMD

ACCESSWIRE

10 months ago

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Kellner Seeking Expedited Appeal of Delaware Court Finding that Nomination Notice was Properly Denied
ZCMD

PR Newswire

10 months ago

Kellner Seeking Expedited Appeal of Delaware Court Finding that Nomination Notice was Properly Denied

Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12
ZCMD

PR Newswire

10 months ago

Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
ZCMD

GlobeNewswire

10 months ago

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees

ZCMD

Business Wire

a year ago

Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid

Zhongchao First Half 2023 Earnings: US$0.18 loss per share (vs US$0.004 profit in 1H 2022)
ZCMD

Simply Wall St.

a year ago

Zhongchao First Half 2023 Earnings: US$0.18 loss per share (vs US$0.004 profit in 1H 2022)

Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma
ZCMD

GlobeNewswire

a year ago

Oncternal Therapeutics Updates the Status of its Phase 1/2 Study of ONCT-808, a ROR1-Targeting Autologous CAR T, in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma

Banzai Launches Data-Driven Research Hub to Democratize Marketing Insights
ZCMD

GlobeNewswire

a year ago

Banzai Launches Data-Driven Research Hub to Democratize Marketing Insights

Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO
ZCMD

GlobeNewswire

a year ago

Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO

ZCMD

PR Newswire

a year ago

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

Yoshitsu Co., Ltd Announces the Launch of its U.S. Direct-Sale Store in Seattle’s University District
ZCMD

GlobeNewswire

a year ago

Yoshitsu Co., Ltd Announces the Launch of its U.S. Direct-Sale Store in Seattle’s University District

ZCMD

PR Newswire

a year ago

The9 Limited Raised US$12 million in a Private Placement Transaction to Fund Business Growth

ZCMD

Business Wire

a year ago

AIM ImmunoTech Provides Update Regarding Annual Meeting

Loss-Making Outlook Therapeutics, Inc. (NASDAQ:OTLK) Expected To Breakeven In The Medium-Term
ZCMD

Simply Wall St.

a year ago

Loss-Making Outlook Therapeutics, Inc. (NASDAQ:OTLK) Expected To Breakeven In The Medium-Term

AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents
ZCMD

GlobeNewswire

a year ago

AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents

Golden Matrix Achieves Record Revenues Exceeding $44 Million in Fiscal 2023
ZCMD

GlobeNewswire

a year ago

Golden Matrix Achieves Record Revenues Exceeding $44 Million in Fiscal 2023

ZCMD

PR Newswire

a year ago

The9 Limited to Hold Annual General Meeting on December 22, 2023

Closed-end funds advised by Allspring Funds Management renew share repurchase programs
ZCMD

PR Newswire

a year ago

Closed-end funds advised by Allspring Funds Management renew share repurchase programs

Aware and Serban Group Team Up To Create Biometric Authentication Powerhouse Serving Latin American and European Markets
ZCMD

GlobeNewswire

a year ago

Aware and Serban Group Team Up To Create Biometric Authentication Powerhouse Serving Latin American and European Markets

BTCS Reports Q3 2023 Results
ZCMD

GlobeNewswire

a year ago

BTCS Reports Q3 2023 Results

ZCMD

GuruFocus.com

a year ago

CareMax Inc (CMAX) Reports Growth Amidst Challenges in Q3 2023

CareMax Reports Third Quarter 2023 Results
ZCMD

Business Wire

a year ago

CareMax Reports Third Quarter 2023 Results

FAZE CLAN AND STEELSERIES LAUNCH CO-BRANDED GAMING GEAR AS PART OF MULTI-YEAR PARTNERSHIP
ZCMD

PR Newswire

a year ago

FAZE CLAN AND STEELSERIES LAUNCH CO-BRANDED GAMING GEAR AS PART OF MULTI-YEAR PARTNERSHIP

Xilio to Host Virtual Investor Conference Call and Webcast on Monday, November 6, 2023 to Review Progress Across Pipeline, Including Phase 1/2 Clinical Data for XTX202, a Tumor-Activated, Engineered, Beta-Gamma IL-2, Presented at the SITC Annual Meeting
ZCMD

GlobeNewswire

a year ago

Xilio to Host Virtual Investor Conference Call and Webcast on Monday, November 6, 2023 to Review Progress Across Pipeline, Including Phase 1/2 Clinical Data for XTX202, a Tumor-Activated, Engineered, Beta-Gamma IL-2, Presented at the SITC Annual Meeting

12 Best Stocks For Day Trading
ZCMD

Insider Monkey

a year ago

12 Best Stocks For Day Trading

Share on Social Networks: